152 related articles for article (PubMed ID: 29243990)
1. Quantification of Plasma Cell-Free Circulating DNA at Different Stages of Colorectal Cancer.
Agah S; Akbari A; Talebi A; Masoudi M; Sarveazad A; Mirzaei A; Nazmi F
Cancer Invest; 2017 Nov; 35(10):625-632. PubMed ID: 29243990
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumor DNA methylation marker MYO1-G for diagnosis and monitoring of colorectal cancer.
Lin WH; Xiao J; Ye ZY; Wei DL; Zhai XH; Xu RH; Zeng ZL; Luo HY
Clin Epigenetics; 2021 Dec; 13(1):232. PubMed ID: 34961566
[TBL] [Abstract][Full Text] [Related]
3. Multiplexed real-time polymerase chain reaction cell-free DNA assay as a potential method to monitor stage IV colorectal cancer.
Sinha S; Brown H; Tabak J; Fang Z; Tertre MCD; McNamara S; Gambaro K; Batist G; Buell JF
Surgery; 2019 Oct; 166(4):534-539. PubMed ID: 31378479
[TBL] [Abstract][Full Text] [Related]
4. Combined identification of long non-coding RNA CCAT1 and HOTAIR in serum as an effective screening for colorectal carcinoma.
Zhao W; Song M; Zhang J; Kuerban M; Wang H
Int J Clin Exp Pathol; 2015; 8(11):14131-40. PubMed ID: 26823726
[TBL] [Abstract][Full Text] [Related]
5. Circulating cell-free DNA in plasma of colorectal cancer patients - A potential biomarker for tumor burden.
Bhangu JS; Taghizadeh H; Braunschmid T; Bachleitner-Hofmann T; Mannhalter C
Surg Oncol; 2017 Dec; 26(4):395-401. PubMed ID: 29113658
[TBL] [Abstract][Full Text] [Related]
6. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
Lv ZC; Fan YS; Chen HB; Zhao DW
Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214
[TBL] [Abstract][Full Text] [Related]
7. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
[TBL] [Abstract][Full Text] [Related]
8. A plasma microRNA panel for early detection of colorectal cancer.
Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
[TBL] [Abstract][Full Text] [Related]
9. LINE-1 hypomethylation status of circulating cell-free DNA in plasma as a biomarker for colorectal cancer.
Nagai Y; Sunami E; Yamamoto Y; Hata K; Okada S; Murono K; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Kawai K; Nozawa H; Ishihara S; Hoon DS; Watanabe T
Oncotarget; 2017 Feb; 8(7):11906-11916. PubMed ID: 28060757
[TBL] [Abstract][Full Text] [Related]
10. Spectrin repeat containing nuclear envelope 1 and forkhead box protein E1 are promising markers for the detection of colorectal cancer in blood.
Melotte V; Yi JM; Lentjes MH; Smits KM; Van Neste L; Niessen HE; Wouters KA; Louwagie J; Schuebel KE; Herman JG; Baylin SB; van Criekinge W; Meijer GA; Ahuja N; van Engeland M
Cancer Prev Res (Phila); 2015 Feb; 8(2):157-64. PubMed ID: 25538088
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylated DNA, a circulating biomarker for colorectal cancer detection.
Rasmussen SL; Krarup HB; Sunesen KG; Johansen MB; Stender MT; Pedersen IS; Madsen PH; Thorlacius-Ussing O
PLoS One; 2017; 12(7):e0180809. PubMed ID: 28700744
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of hsa_circ_001988 in colorectal cancer and its clinical significances.
Wang X; Zhang Y; Huang L; Zhang J; Pan F; Li B; Yan Y; Jia B; Liu H; Li S; Zheng W
Int J Clin Exp Pathol; 2015; 8(12):16020-5. PubMed ID: 26884878
[TBL] [Abstract][Full Text] [Related]
13. Droplet digital PCR for quantification of
Herring E; Kanaoka S; Tremblay É; Beaulieu JF
World J Gastroenterol; 2017 Apr; 23(16):2891-2898. PubMed ID: 28522907
[TBL] [Abstract][Full Text] [Related]
14. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients.
Du M; Liu S; Gu D; Wang Q; Zhu L; Kang M; Shi D; Chu H; Tong N; Chen J; Adams TS; Zhang Z; Wang M
Carcinogenesis; 2014 Dec; 35(12):2723-30. PubMed ID: 25239640
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
[TBL] [Abstract][Full Text] [Related]
16. Histone Methylation Marks on Circulating Nucleosomes as Novel Blood-Based Biomarker in Colorectal Cancer.
Gezer U; Yörüker EE; Keskin M; Kulle CB; Dharuman Y; Holdenrieder S
Int J Mol Sci; 2015 Dec; 16(12):29654-62. PubMed ID: 26690425
[TBL] [Abstract][Full Text] [Related]
17. Serum microRNA-135a-5p as an auxiliary diagnostic biomarker for colorectal cancer.
Wang Q; Zhang H; Shen X; Ju S
Ann Clin Biochem; 2017 Jan; 54(1):76-85. PubMed ID: 27126269
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and Prognostic Value of miR-1287 in Colorectal Cancer.
Fateh A; Feizi MA; Safaralizadeh R; Azarbarzin S; Ravanbakhsh R
J Gastrointest Cancer; 2016 Dec; 47(4):399-403. PubMed ID: 27251300
[TBL] [Abstract][Full Text] [Related]
19. Real-time polymerase chain reaction quantification of free DNA in serum of patients with polyps and colorectal cancers.
Danese E; Montagnana M; Minicozzi AM; De Matteis G; Scudo G; Salvagno GL; Cordiano C; Lippi G; Guidi GC
Clin Chem Lab Med; 2010 Nov; 48(11):1665-8. PubMed ID: 20704532
[TBL] [Abstract][Full Text] [Related]
20. Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer.
Wang H; Zhang X; Wang L; Zheng G; Du L; Yang Y; Dong Z; Liu Y; Qu A; Wang C
J Surg Oncol; 2014 May; 109(6):574-9. PubMed ID: 24338523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
